The discovery of putative urine markers for the specific detection of prostate tumor by integrative mining of public genomic profiles

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Chen, Min ^a   Wang, Kai ^b   Zhang, Liang ^a   Li, Cheng ^b   Yang, Yongliang ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; APOLIPOPROTEIN D; BINDING PROTEIN; BIOLOGICAL MARKER; CD27 ANTIGEN; CD31 ANTIGEN; CELLULAR RETINOIC ACID BINDING PROTEIN 1; CLUSTERIN; COMPLEMENT FACTOR H; DIMETHYLARGININASE; DIMETHYLARGININE DIMETHLAMINOHYDROLASE 2; FERRITIN; FERRITIN, LIGHT POLYPEPTIDE; GALAPTIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN SUPERFAMILY, MEMBER 8; INTER ALPHA (GLOBULIN) INHIBITOR H4; LYSOZYME; MATRIX METALLOPROTEINASE INHIBITOR; PROTEIN; RETINOIC ACID BINDING PROTEIN; RETINOL BINDING PROTEIN 4; REVERSION INDUCING CYSTEINE RICH PROTEIN; SELENIUM BINDING PROTEIN 1; SLIT HOMOLOG 2; UNCLASSIFIED DRUG; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BLADDER; BODY FLUID; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DATA BASE; GENOMICS; KIDNEY PARENCHYMA; PROGNOSIS; PROSTATE; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH; URINE; DATA MINING; DISEASE COURSE; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; PROSTATE TUMOR; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY;

DATA MINING; DATABASES, GENETIC; DISEASE PROGRESSION; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; PROTEIN INTERACTION MAPPING; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 83455255600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028552     Document Type: Article

References (30)

1. Yang Y, Adelstein J, Kassis AI, (2010) Putative molecular signatures for the imaging of prostate cancer. Expert Rev Mol Diagn 10 (1): 65-74.
2. Jemal A, Murray T, Samuels A, Ghafoor A, (2003) Cancer statistics 2003. CA Cancer J Clin 53: 5-26.
3. Bensalah K, Lotan Y, Karam JA, Shariat SF, (2008) New circulating biomarkers for prostate cancer. Prostate Cancer Prostatic Dis 11 pp. 112-120.
4. Yang Y, Iyer LK, Adelstein SJ, Kassis AI, (2008) Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. PLoS ONE 3: e3661.
5. Müller H, Brenner H, (2006) Urine markers as possible tools for prostate cancer screening: review of performance characteristics and practicality. Clin Chem 52 (4): 562-73.
6. Downes MR, Byrne JC, Pennington SR, Dunn MJ, Fitzpatrick JM, et al. (2007) Urinary markers for prostate cancer. BJU Int 99 (2): 263-8.
7. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457 (7231): 910-4.
8. Yang Y, Adelstein SJ, Kassis AI, (2009) Target discovery from data mining approaches. Drug Discov Today 14: 147-154.
9. Kim B, Lee HJ, Choi HY, Shin Y, Nam S, et al. (2007) Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Cancer Res 67 (15): 7431-7438.
10. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9: 166-180.
11. Parkinson H, Kapushesky M, Shojatalab M, Abeygunawardena N, Coulson R, et al. (2007) ArrayExpress-a public database of microarray experiments and gene expression profiles. Nucleic Acids Res35 (Database issue): D747-50.
12. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (9): 5116-21.
13. Cline MS, Smoot M, Cerami E, Kuchinsky A, Workman C, et al. (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2 (10): 2366-82.
14. Gnad F, Oroshi M, Birney E, Mann M, (2009) MAPU 2.0: high-accuracy proteomes mapped to genomes. Nucleic Acids Res37 (Database issue): D902-6.
15. Li SJ, Peng M, Li H, Liu BS, et al. (2009) Sys-BodyFluid: a systematical database for human body fluid proteome research. Nucleic Acids Res2009; 37 (Database issue): D907-12.
16. Ingenuity® Systems website, www.ingenuity.com Accessed 2010 Feb 14.
17. Finn RD, Mistry J, Tate J, Coggill P, Heger A, et al. (2010) The Pfam protein families database. Nucleic Acids Res38 (Database issue): D211-22.
18. Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, et al. (2009) InterPro: the integrative protein signature database. Nucleic Acids Res37 (Database Issue): D224-228.
19. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M, (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res38: D355-D360.
20. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T, (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27 (3): 431-2.
21. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, et al. (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res38 (Web Server issue): W214-20.
22. Wang Y, Nangia-Makker P, Tait L, Balan V, Hogan V, et al. (2009) Regulation of prostate cancer progression by galectin-3. Am J Pathol 174 (4): 1515-23.
23. Sardana G, Marshall J, Diamandis EP, (2007) Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin Chem 53 (3): 429-37.
24. Kentsis A, Lin YY, Kurek K, Calicchio M, Wang YY, et al. (2010) Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry. Ann Emerg Med 55 (1): 62-70.e4.
25. Aspinall JO, Bentel JM, Horsfall DJ, Haagensen DE, Marshall VR, et al. (1995) Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues. J Urol 154 (2 Pt 1): 622-8.
26. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, et al. (2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellularmatrix integrity and angiogenesis. Cell 107 (6): 789-800.
27. Ilan N, Madri JA, (2004) PECAM-1: old friend, new partners. Curr Opin Cell Biol 15 (5): 515-24.
28. Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, (2001) Angiogenesis and prostate cancer: identification of a molecular progression switch. Cancer Res 61 (6): 2736-43.
29. Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, et al. (2009) A network model of a cooperative genetic landscape in brain tumors. JAMA 302 (3): 261-75.
30. Newman MEJ, (2010) Networks: An Introduction Oxford, UK Oxford University Press.